Leqembi: payments to doctors
Payments that named Leqembi as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8.8M
- Providers
- 17,578
- Transactions
- 73,563
- Average per transaction
- $119
The per-transaction average — $119 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 17,578 providers the average total is $499, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Eisai Inc. | $8,597,112 | 98.0% |
| Biogen | $128,217 | 1.5% |
| Eisai Co., Ltd. | $51,066 | 0.6% |